{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:39:11Z","timestamp":1789886351694,"version":"4.0.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007801","name":"Fundaci\u00f3n S\u00e9neca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/0163"],"award-info":[{"award-number":["PI14\/0163"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004687","name":"Universidad de Murcia","doi-asserted-by":"publisher","award":["16\/00172"],"award-info":[{"award-number":["16\/00172"]}],"id":[{"id":"10.13039\/501100004687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004687","name":"Universidad de Murcia","doi-asserted-by":"publisher","award":["INT 15\/00108"],"award-info":[{"award-number":["INT 15\/00108"]}],"id":[{"id":"10.13039\/501100004687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.trsl.2018.04.004","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T13:28:40Z","timestamp":1524490120000},"page":"4-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Pharmacological inhibition of the mitochondrial NADPH oxidase 4\/PKC\u03b1\/Gal-3 pathway reduces left ventricular fibrosis following myocardial infarction"],"prefix":"10.1016","volume":"199","author":[{"given":"Maria del Carmen","family":"Asensio-Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Josefa","family":"Fernandez del Palacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassine","family":"Sassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J.","family":"Hajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domingo A.","family":"Pascual-Figal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2018.04.004_bib0010","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2018.04.004_bib0015","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2018.04.004_bib0020","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2337\/db07-1098","article-title":"Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling","volume":"57","author":"Calvert","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2018.04.004_bib0025","doi-asserted-by":"crossref","first-page":"L844","DOI":"10.1152\/ajplung.00173.2013","article-title":"Metformin-stimulated AMPK-\u03b11 promotes microvascular repair in acute lung injury","volume":"305","author":"Jian","year":"2013","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.trsl.2018.04.004_bib0030","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/FJC.0b013e31819fd4e7","article-title":"Metformin prevents myocardial reperfusion injury by activating the adenosine receptor","volume":"53","author":"Paiva","year":"2009","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.trsl.2018.04.004_bib0035","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1161\/CIRCRESAHA.108.190918","article-title":"Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure","volume":"104","author":"Gundewar","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2018.04.004_bib0040","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1161\/CIRCULATIONAHA.108.798561","article-title":"Metformin prevents progression of heart failure in dogs: role of amp-activated protein kinase","volume":"119","author":"Sasaki","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2018.04.004_bib0045","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/CIRCULATIONAHA.114.011079","article-title":"NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt\/mTOR and NF B signaling pathways","volume":"131","author":"Zhao","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2018.04.004_bib0050","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm1000","article-title":"PKC-\u03b1 regulates cardiac contractility and propensity toward heart failure","volume":"10","author":"Braz","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2018.04.004_bib0055","doi-asserted-by":"crossref","first-page":"14385","DOI":"10.1073\/pnas.0906805106","article-title":"Subcellular localization of Nox4 and regulation in diabetes","volume":"106","author":"Block","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2018.04.004_bib0060","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/CIRCRESAHA.109.213116","article-title":"Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes","volume":"106","author":"Ago","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2018.04.004_bib0065","doi-asserted-by":"crossref","first-page":"15565","DOI":"10.1073\/pnas.1002178107","article-title":"NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart","volume":"107","author":"Kuroda","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2018.04.004_bib0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/cvr\/cvp001","article-title":"Protein kinase C in heart failure: a therapeutic target?","volume":"82","author":"Palaniyandi","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.trsl.2018.04.004_bib0075","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.yjmcc.2005.03.008","article-title":"Inhibition of protein kinase C reduces left ventricular fibrosis and dysfunction following myocardial infarction","volume":"39","author":"Boyle","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.trsl.2018.04.004_bib0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCRESAHA.107.148288","article-title":"Augmented protein kinase C-alpha-induced myofilament protein phosphorylation contributes to myofilament dysfunction in experimental congestive heart failure","volume":"101","author":"Belin","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2018.04.004_bib0085","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1161\/01.CIR.99.3.384","article-title":"Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart","volume":"99","author":"Bowling","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2018.04.004_bib0090","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.yjmcc.2011.08.025","article-title":"Pharmacological inhibition of \u03b2IIPKC is cardioprotective in late-stage hypertrophy","volume":"51","author":"Ferreira","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.trsl.2018.04.004_bib0095","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1073\/pnas.86.17.6758","article-title":"Ca2+- and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain","volume":"86","author":"Gopalakrishna","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2018.04.004_bib0100","doi-asserted-by":"crossref","first-page":"H404","DOI":"10.1152\/ajpheart.00747.2008","article-title":"N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion\/growth-regulatory lectin","volume":"296","author":"Liu","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.trsl.2018.04.004_bib0105","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2018.04.004_bib0110","doi-asserted-by":"crossref","first-page":"18938","DOI":"10.1074\/jbc.M209673200","article-title":"Stimulation of proliferation of rat hepatic stellate cells by galectin-1 and galectin-3 through different intracellular signaling pathways","volume":"278","author":"Maeda","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2018.04.004_bib0115","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/(SICI)1096-9896(199903)187:4<481::AID-PATH263>3.0.CO;2-2","article-title":"Galectin-3 modulates rat mesangial cell proliferation and matrix synthesis during experimental glomerulonephritis induced by anti-Thy1.1 antibodies","volume":"187","author":"Sasaki","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.trsl.2018.04.004_bib0120","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2015-0074","article-title":"Clinical relevance of sST2 in cardiac diseases","volume":"54","author":"Pascual-Figal","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.trsl.2018.04.004_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2013.12.129","article-title":"Galectin-3 expression in cardiac remodeling after myocardial infarction","volume":"172","author":"Sanchez-Mas","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.trsl.2018.04.004_bib0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2015.06.025","article-title":"Galectin-3 and post-myocardial infarction cardiac remodeling","volume":"763","author":"Meijers","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.trsl.2018.04.004_bib0135","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/jcp.25210","article-title":"The Nox1\/4 dual inhibitor GKT137831 or Nox4 knockdown inhibits angiotensin-II-Induced adult mouse cardiac fibroblast proliferation and migration. AT1 physically associates with Nox4","volume":"231","author":"Somanna","year":"2016","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.trsl.2018.04.004_bib0140","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.bbamcr.2014.12.001","article-title":"Protein kinase C promotes cardiac fibrosis and heart failure by modulating galectin-3 expression","volume":"1853","author":"Song","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.trsl.2018.04.004_bib0145","first-page":"563","article-title":"Estimating systemic fibrosis by combining galectin-3 and ST2 provides powerful risk stratification value for patients after acute decompensated heart failure","volume":"23","author":"Wang","year":"2016","journal-title":"Cardiol J"},{"key":"10.1016\/j.trsl.2018.04.004_bib0150","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.1158\/0008-5472.CAN-06-4447","article-title":"Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth","volume":"67","author":"Buzzai","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2018.04.004_bib0155","doi-asserted-by":"crossref","first-page":"43940","DOI":"10.1074\/jbc.M404421200","article-title":"Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species","volume":"279","author":"Zou","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2018.04.004_bib0160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.yjmcc.2014.11.003","article-title":"Cyclic stretch of embryonic cardiomyocytes increases proliferation, growth, and expression while repressing Tgf-\u03b2 signaling","volume":"79","author":"Banerjee","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.trsl.2018.04.004_bib0165","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.freeradbiomed.2011.08.015","article-title":"Metformin protects against doxorubicin-induced cardiotoxicity: involvement of the adiponectin cardiac system","volume":"51","author":"Asensio-L\u00f3pez","year":"2011","journal-title":"Free Radic Biol Med"},{"issue":"pt 3","key":"10.1016\/j.trsl.2018.04.004_bib0170","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain","volume":"348","author":"Owen","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.trsl.2018.04.004_bib0175","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.abb.2016.02.021","article-title":"Early oxidative damage induced by doxorubicin: source of production, protection by GKT137831 and effect on Ca2+ transporters in HL-1 cardiomyocytes","volume":"594","author":"Asensio-L\u00f3pez","year":"2016","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.trsl.2018.04.004_bib0180","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal Biochem"},{"key":"10.1016\/j.trsl.2018.04.004_bib0185","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.RES.74.6.1141","article-title":"Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells","volume":"74","author":"Griendling","year":"1994","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2018.04.004_bib0190","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/cvr\/cvq066","article-title":"Metformin attenuates cardiac fibrosis by inhibiting the TGF 1-Smad3 signalling pathway","volume":"87","author":"Xiao","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.trsl.2018.04.004_bib0195","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.redox.2017.08.018","article-title":"Metformin selectively targets redox control of complex I energy transduction","volume":"14","author":"Cameron","year":"2017","journal-title":"Redox Biol"},{"key":"10.1016\/j.trsl.2018.04.004_bib0200","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.2337\/db09-1679","article-title":"Role of KLF15 in regulation of hepatic gluconeogenesis and metformin action","volume":"59","author":"Takashima","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2018.04.004_bib0205","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2018.04.004_bib0210","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/HYPERTENSIONAHA.108.114702","article-title":"AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice","volume":"52","author":"Zhang","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.trsl.2018.04.004_bib0215","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.yjmcc.2016.01.001","article-title":"AMPK in cardiac fibrosis and repair: actions beyond metabolic regulation","volume":"91","author":"Daskalopoulos","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.trsl.2018.04.004_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/1656450","article-title":"The role of oxidative stress in myocardial ischemia and reperfusion injury and remodeling: revisited","volume":"2016","author":"Kurian","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.trsl.2018.04.004_bib0225","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1161\/CIRCULATIONAHA.105.582239","article-title":"Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice","volume":"113","author":"Matsushima","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2018.04.004_bib0230","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.freeradbiomed.2014.01.027","article-title":"NADPH oxidase 4 promotes cardiac microvascular angiogenesis after hypoxia\/reoxygenation in vitro","volume":"69","author":"Wang","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.trsl.2018.04.004_bib0235","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12931-016-0420-x","article-title":"Metformin attenuates lung fibrosis development via NOX4 suppression","volume":"17","author":"Sato","year":"2016","journal-title":"Respir Res"},{"key":"10.1016\/j.trsl.2018.04.004_bib0240","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00109-016-1451-y","article-title":"Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK\/NOX4\/ROS pathway","volume":"94","author":"He","year":"2016","journal-title":"J Mol Med"},{"key":"10.1016\/j.trsl.2018.04.004_bib0245","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.molmed.2007.04.002","article-title":"mTOR complex1\u2013S6K1 signaling: at the crossroads of obesity, diabetes and cancer","volume":"13","author":"Dann","year":"2007","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.trsl.2018.04.004_bib0250","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.2337\/db12-1504","article-title":"Mammalian target of rapamycin regulates Nox4-mediated podocyte depletion in diabetic renal injury","volume":"62","author":"Eid","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2018.04.004_bib0255","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/CIRCRESAHA.117.311147","article-title":"New insights into the role of mTOR signaling in the cardiovascular system","volume":"122","author":"Sciarretta","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2018.04.004_bib0260","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.freeradbiomed.2018.03.006","article-title":"Nitrite exerts antioxidant effects, inhibits the mTOR pathway and reverses hypertension-induced cardiac hypertrophy","volume":"120","author":"Guimaraes","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.trsl.2018.04.004_bib0265","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.jacc.2009.08.031","article-title":"Beneficial effects of mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction","volume":"54","author":"Buss","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.trsl.2018.04.004_bib0270","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1161\/CIRCULATIONAHA.113.003638","article-title":"Mechanistic target of rapamycin complex 2 protects the heart from ischemic damage","volume":"128","author":"V\u00f6lkers","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2018.04.004_bib0275","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.bbrc.2005.12.012","article-title":"Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice","volume":"340","author":"Sakaguchi","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2018.04.004_bib0280","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCRESAHA.107.148288","article-title":"Augmented protein kinase C-induced myofilament protein phosphorylation contributes to myofilament dysfunction in experimental congestive heart failure","volume":"101","author":"Belin","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2018.04.004_bib0285","doi-asserted-by":"crossref","first-page":"e12192","DOI":"10.14814\/phy2.12192","article-title":"Nox-4 deletion reduces oxidative stress and injury by PKC-associated mechanisms in diabetic nephropathy","volume":"2","author":"Thallas-Bonke","year":"2014","journal-title":"Physiol Rep"},{"key":"10.1016\/j.trsl.2018.04.004_bib0290","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.3390\/ijms130910697","article-title":"Cell signaling through protein kinase C oxidation and activation","volume":"13","author":"Cosentino-Gomes","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2018.04.004_bib0295","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.yjmcc.2016.07.006","article-title":"Metformin inhibits aldosterone-induced cardiac fibroblast activation, migration and proliferation in vitro, and reverses aldosterone+salt-induced cardiac fibrosis in vivo","volume":"98","author":"Mummidi","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.trsl.2018.04.004_bib0300","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1073\/pnas.0511167103","article-title":"Galectin-3 regulates myofibroblast activation and hepatic fibrosis","volume":"103","author":"Henderson","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.trsl.2018.04.004_bib0305","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/HYPERTENSIONAHA.115.05876","article-title":"Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension novelty and significance","volume":"66","author":"Mart\u00ednez-Mart\u00ednez","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.trsl.2018.04.004_bib0310","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.trsl.2017.09.003","article-title":"Metformin attenuates ER stress-induced mitochondrial dysfunction","volume":"190","author":"Chen","year":"2017","journal-title":"Transl Res"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524418300586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524418300586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:36:28Z","timestamp":1761827788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524418300586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":61,"alternative-id":["S1931524418300586"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2018.04.004","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological inhibition of the mitochondrial NADPH oxidase 4\/PKC\u03b1\/Gal-3 pathway reduces left ventricular fibrosis following myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2018.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}